Resource Library

Gain guidance on misconceptions around the cost-effectiveness of electronic patient-reported outcomes (ePRO) and key points to consider when evaluating ePRO.

Collecting participant data securely is a critical part of running any clinical trial, whether it is decentralized, in-clinic, or somewhere in between. Medrio EDC and ePRO solutions are important assets that help CROs and sponsors do more with less.

Participant education is a critical part of informed consent and one that is easy to improve by leveraging established patient education best practices. Medrio CEO Nicole Latimer discusses some of the most successful approaches she has seen in her career:

Many early phase studies rely on manual methods of managing participant randomization and the study supply chain. But increasing complexities in both study design and global supply chain necessitate more flexible, responsive solutions for early phase studies, in particular. 

Does your CRO or sponsor have a policy around IP numbering in clinical trials? If not, they could be putting your clinical trial at risk.

San Francisco, CA (August 19, 2022) — Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions.